Regulatory Affairs Contractor Rates in Europe: What EU MDR Means for Hiring Budgets in 2026

As EU MDR compliance deadlines converge in 2026, regulatory affairs contractor rates across Europe are under pressure. Here is what hiring managers need to know, with data from the EPM Scientific Europe Life Sciences Rates Guide.

 

The EU MDR compliance window is closing and regulatory affairs talent was already scarce

The MedTech industry has been navigating EU MDR compliance since 2021. But 2026 represents a different kind of challenge. Several compliance deadlines are landing at the same time, across an industry where experienced regulatory affairs contractors are in short supply.

For hiring managers, contractor rates in regulatory affairs have shifted, the profiles needed to meet MDR requirements are harder to secure, and budgets set against previous years may not reflect the market as it stands today.

 

What is EU MDR and why does it matter for medical device manufacturers?

The EU Medical Device Regulation, known as EU MDR, is the regulatory framework governing how medical devices are approved, monitored and sold across the European Union. It came into full force in May 2021, replacing the previous Medical Device Directive, or MDD, which had been in place since 1993. Where the MDD set relatively broad requirements, MDR introduced far stricter standards for clinical evidence, technical documentation, post-market surveillance and the ongoing monitoring of devices already on the market.

For manufacturers, the shift meant that devices previously certified under MDD could not simply carry over their approval. Every device needs to go through a conformity assessment under Regulation (EU) 2017/745, conducted by an independent notified body. That process takes time and requires dedicated regulatory expertise to navigate.

 

What is EUDAMED and why is 2026 the critical year?

EUDAMED is the EU's central database for medical devices, built to sit alongside MDR and provide a single source of regulatory truth across the bloc. It covers device registration, unique device identifiers, certificates issued by notified bodies, and post-market surveillance data.

Although its six modules have been introduced in stages, 2026 marks the point at which EUDAMED shifts from a voluntary system to a mandatory one for manufacturers. For organizations that have treated it as a future concern rather than an operational priority, that shift is now close enough to require immediate action.

 

Three significant MDR compliance deadlines are landing at once in 2026

In 2026, three significant compliance milestones are arriving at the same time, and the pressure on regulatory affairs teams across Europe is greater than it has been at any point since the regulation came into force.

EUDAMED Becomes mandatory on 28 May 2026

From 28 May 2026, manufacturers must have completed device registration, obtained a Single Registration Number, and aligned internal processes with EUDAMED before placing any new product on the EU market. For organizations that have not yet started, this is not a minor administrative task. It requires dedicated regulatory resource to deliver against a fixed deadline.

Class III custom-cade implantable devices reach their MDR compliance deadline

Manufacturers of Class III custom-made implantable devices still operating under legacy Medical Device Directive certificates must have transitioned to MDR by 26 May 2026 under Regulation (EU) 2023/607. Notified bodies, the independent organizations that assess and certify medical devices for EU market access, are currently quoting review timelines of 13 to 18 months. For any manufacturer that has not already submitted, the window has closed.

MDR requires a dedicated person responsible for regulatory compliance

The Person Responsible for Regulatory Compliance, or PRRC, is a designated individual required under MDR for every manufacturer and authorised representative operating in the EU. This cannot be absorbed into an existing role. It requires a qualified professional with a specific combination of regulatory experience and device knowledge, and demand for people who meet that profile has been running ahead of supply for some time.

These three milestones sit on top of ongoing post-market surveillance obligations, continuous clinical evaluation requirements, and a targeted revision of the MDR framework currently underway at the European Commission. The regulatory environment is not settling. It is still evolving.

MDR is not the only regulatory development affecting medical device hiring across Europe right now. For a broader view of what is moving the market in 2026, visit our industry insights.

Visit Industry Insights →

 

The regulatory affairs talent shortage is structural, not cyclical

Demand for experienced regulatory affairs professionals in medical devices has outpaced supply for years, and the changes to MDR have only worked to widen that gap. Unlike many technical disciplines, regulatory affairs expertise is built primarily through experience rather than formal education, which means the pipeline is slow to respond to spikes in demand, regardless of how acute they become.

The regulation demands deeper technical documentation, more rigorous clinical evaluation and continuous post-market surveillance, none of which are one-time tasks. They represent an ongoing workload, and the contractors who can deliver against them are aware of their position in the market.

The notified body system adds further pressure. There are still too few designated notified bodies across Europe relative to the volume of applications, and incomplete submissions remain the leading cause of delays. For manufacturers, strong internal regulatory expertise is no longer just a compliance requirement. It is a commercial one.

 

Regulatory affairs contractor rates across Europe in 2026

Contractor rates in regulatory affairs across Europe reflect the shortage described above. They sit consistently at the higher end of the medical devices market, and the differences between countries are significant enough to materially affect what a realistic budget looks like.

Country	Specialist (per hour)	Manager (per hour)	Director (per hour)
United Kingdom	£70	£98	£107
Ireland	€61	€86	€104
France	€64	€91	€109
Germany	€67	€95	€113
Netherlands	€77	€98	€119
Spain	€98	€143	€173
Norway	817kr	1,253kr	1,544kr
Sweden	728kr	1,117kr	1,375kr

Source: EPM Scientific Europe Life Sciences Rates Guide 2026. Rates reflect contract market placement data

For a full picture of Life Science rates across Europe, the 2026 EPM Scientific Europe Life Sciences Rates Guide is available to download now.

Download the 2026 European Rates Guide →

 

Spain: A warning for organizations hiring on cost assumptions

Spain is often considered a more affordable market for contractor talent. In regulatory affairs, that assumption does not hold. Rates at director level sit above France and Germany. Strong demand from multinational manufacturers running EU regulatory hub operations in Spain has outpaced the local supply of MDR-qualified contractors. For any organization with hiring plans there, budgets need to reflect that reality before going to market, not after.

Seniority carries a bigger premium in regulatory affairs than in other functions

The jump from specialist to director level is steeper in regulatory affairs than in most other areas of the medical devices sector. Contractors who combine MDR expertise, notified body experience and PRRC qualification represent a small pool across Europe. Budgeting for a senior regulatory affairs contractor requires a different conversation than budgeting for a senior hire in most other functions.

The UK and Ireland are not interchangeable

Both markets are commonly grouped together for English-speaking remote regulatory work, but the rates tell a different story. UK regulatory affairs contractors sit higher than their Irish counterparts at every seniority level. For organizations building flexible contractor teams across both markets, that difference adds up over the course of an engagement.

The Nordics Are consistently at the top end of the European market

Norway in particular sits above most other European markets across all seniority levels. For organizations with operations in Scandinavia this is worth factoring into budget planning early, as Nordic regulatory affairs contractor rates are frequently underestimated relative to the rest of Europe.

Taken together, the rates data points to a market where geography, seniority and timing all have a meaningful bearing on what a realistic regulatory affairs contractor budget looks like in 2026.

 

Building a regulatory affairs contractor budget that reflects the market

Regulatory affairs contractors with genuine MDR experience are in short supply across Europe, and the 2026 deadlines have made competition for that talent more acute than at any previous point in the transition.

In our experience, the organizations that secure the right people are not always the ones with the biggest budgets. They are the ones that engage early, understand the market they are hiring in, and work with specialists who have direct access to the contractors they need.

EPM Scientific specializes in placing regulatory affairs professionals across the European medical devices and life sciences market. Our contracts team has established networks across every seniority level and every major market in Europe. We understand the profiles that MDR compliance demands and have a proven track record of placing them when it matters most.

If you have a role to fill or a team to build ahead of the MDR deadlines, submit a vacancy or speak to our contracts team.

Request a call back →   Submit a vacancy →